EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Advancing Leukemia Diagnosis and Treatment: WHO-Supported Laboratory Innovations in Africa- A Narrative Review

Emmanuel Ifeanyi Obeagu iD

Blood and Lymphatic Cancer: Targets and Therapy · 2025-06 · Volume 15 · 47-67

DOI: 10.2147/blctt.s518005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Blood and Lymphatic Cancer: Targets and Therapy, 2025-06. Verfasst von Emmanuel Ifeanyi Obeagu. Beteiligte Einrichtung: Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimababwe. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

AfricaWHO supporthealthcare improvementlaboratory innovationsleukemia diagnosis

Autor:innen und Institutionen

  • Department of Biomedical and Laboratory Science, Africa University, Mutare, Zimababwe.
  • Department of Medical Laboratory Science, Kampala International University, Ishaka, Uganda.

ORCID-Profile: Emmanuel Ifeanyi Obeagu

Zitieren

APA

Obeagu, E. I. (2025). Advancing Leukemia Diagnosis and Treatment: WHO-Supported Laboratory Innovations in Africa- A Narrative Review. Blood and Lymphatic Cancer: Targets and Therapy, Volume 15, 47-67. https://doi.org/10.2147/blctt.s518005

Vancouver

Obeagu EI. Advancing Leukemia Diagnosis and Treatment: WHO-Supported Laboratory Innovations in Africa- A Narrative Review. Blood and Lymphatic Cancer: Targets and Therapy. 2025;Volume 15:47-67. doi:10.2147/blctt.s518005

BibTeX
@article{Obeagu2025,
  author = {Obeagu, Emmanuel Ifeanyi},
  title = {Advancing Leukemia Diagnosis and Treatment: WHO-Supported Laboratory Innovations in Africa- A Narrative Review},
  journal = {Blood and Lymphatic Cancer: Targets and Therapy},
  year = {2025},
  volume = {Volume 15},
  pages = {47--67},
  doi = {10.2147/blctt.s518005}
}
Kostenlos starten →